Hutchison China Meditech (HCM) ORD USD0.10
18.00p
(3.59%)
- Add to watchlist
- Create an alert
- This stock can be held in a
18.00p
(3.59%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
18.00p
(3.59%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
486.00p
516.00p
538.00p
£3.52 bn
502.00p
478.00p
250.00p
n/a
6.00p (1.18%) Previous:
6.00p
37,933
n/a
3,000
Performance
| 1 week 1W | 4.2% | 1 year 1Y | 14.09% |
|---|---|---|---|
| 1 month 1M | 16.74% | 2 years 2Y | 49.4% |
| 3 months 3M | 6.81% | 3 years 3Y | 9.22% |
| 6 months 6M | 19.52% | 5 years 5Y | 86.79% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2019 | 31/12/2018 |
|---|---|---|
| Revenue ($m) | 204.89 | 214.11 |
| Profit before tax ($m) | (141.10) | (86.66) |
| Adjusted EPS (¢): | (16.00) | (1.10) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
Hutchison Chi-Med begins latest trial of fruquintinib
4 September 2020 14:13
-
Hutchison Chi-Med begins phase 1 study of 'HMPL-306'
24 July 2020 15:45
-
Hutchison Chi-Med gets FDA fast track approval for fruquintinib
18 June 2020 09:18
-
Total Voting Rights
31 December 2020 07:00
-
Blocklisting Six Monthly Return
31 December 2020 07:00
-
NMPA approval of Surufatinib in China for ep-NET
30 December 2020 12:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.